Tuberculosis

被引:25
作者
Onyebujoh, P
Rook, GAW
机构
关键词
D O I
10.1038/nrmicro1050
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:930 / 932
页数:3
相关论文
共 27 条
[1]   Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high evels of Th1 cytokines and the IL-4 antagonist IL-4δ2 [J].
Demissie, A ;
Abebe, M ;
Aseffa, A ;
Rook, G ;
Fletcher, H ;
Zumla, A ;
Weldingh, K ;
Brock, I ;
Andersen, P ;
Doherty, TM .
JOURNAL OF IMMUNOLOGY, 2004, 172 (11) :6938-6943
[2]   Global trends in resistance to antituberculosis drugs [J].
Espinal, MA ;
Laszlo, A ;
Simonsen, L ;
Boulahbal, F ;
Kim, SJ ;
Reniero, A ;
Hoffner, S ;
Rieder, HL ;
Binkin, N ;
Dye, C ;
Williams, R ;
Raviglione, MC .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (17) :1294-1303
[3]   Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4δ2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation [J].
Fletcher, HA ;
Owiafe, P ;
Jeffries, D ;
Hill, P ;
Rook, GAW ;
Zumla, A ;
Doherty, TM ;
Brookes, RH .
IMMUNOLOGY, 2004, 112 (04) :669-673
[4]   Mycobacterium tuberculosis inhibits macrophage responses to IFN-γ through myeloid differentiation factor 88-dependent and -independent mechanisms [J].
Fortune, SM ;
Solache, A ;
Jaeger, A ;
Hill, PJ ;
Belisle, JT ;
Bloom, BR ;
Rubin, EJ ;
Ernst, JD .
JOURNAL OF IMMUNOLOGY, 2004, 172 (10) :6272-6280
[5]   Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara [J].
Goonetilleke, NP ;
McShane, H ;
Hannan, CM ;
Anderson, RJ ;
Brookes, RH ;
Hill, AVS .
JOURNAL OF IMMUNOLOGY, 2003, 171 (03) :1602-1609
[6]   Pulmonary tuberculosis in BALB/c mice with nonfunctional IL-4 genes:: changes in the inflammatory effects of TNF-α and in the regulation of fibrosis [J].
Hernandez-Pando, R ;
Aguilar, D ;
Hernandez, MLG ;
Orozco, H ;
Rook, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (01) :174-183
[7]   Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection [J].
Hernández-Pando, R ;
Jeyanathan, M ;
Mengistu, G ;
Aguilar, D ;
Orozco, H ;
Harboe, M ;
Rook, GAW ;
Bjune, G .
LANCET, 2000, 356 (9248) :2133-2138
[8]   Mycobacterium bovis bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes [J].
Hess, J ;
Miko, D ;
Catic, A ;
Lehmensiek, V ;
Russell, DG ;
Kaufmann, SHE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) :5299-5304
[9]   Survival perspectives from the world's most successful pathogen, Mycobacterium tuberculosis [J].
Hingley-Wilson, SM ;
Sambandamurthy, VK ;
Jacobs, WR .
NATURE IMMUNOLOGY, 2003, 4 (10) :949-955
[10]   A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis [J].
Horwitz, MA ;
Harth, G .
INFECTION AND IMMUNITY, 2003, 71 (04) :1672-1679